These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10652236)

  • 1. Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption.
    Itzstein C; Espinosa L; Delmas PD; Chenu C
    Biochem Biophys Res Commun; 2000 Feb; 268(1):201-9. PubMed ID: 10652236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
    J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic regulation of bone remodeling.
    Chenu C
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):282-4. PubMed ID: 15758455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
    Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
    Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation.
    Ilvesaro JM; Lakkakorpi PT; Väänänen HK
    Exp Cell Res; 1998 Jul; 242(1):75-83. PubMed ID: 9665804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.
    Peet NM; Grabowski PS; Laketic-Ljubojevic I; Skerry TM
    FASEB J; 1999 Dec; 13(15):2179-85. PubMed ID: 10593865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
    Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
    J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal changes in osteoclasts during the resorption cycle.
    Lakkakorpi PT; Väänänen HK
    Microsc Res Tech; 1996 Feb; 33(2):171-81. PubMed ID: 8845516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical loading modulates glutamate receptor subunit expression in bone.
    Szczesniak AM; Gilbert RW; Mukhida M; Anderson GI
    Bone; 2005 Jul; 37(1):63-73. PubMed ID: 15922681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
    El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
    Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
    Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
    J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate receptors are expressed by bone cells and are involved in bone resorption.
    Chenu C; Serre CM; Raynal C; Burt-Pichat B; Delmas PD
    Bone; 1998 Apr; 22(4):295-9. PubMed ID: 9556127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.
    Lakkakorpi PT; Väänänen HK
    J Bone Miner Res; 1991 Aug; 6(8):817-26. PubMed ID: 1664645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of N-methyl-D-aspartate receptors increases paraoxon-induced apoptosis in cultured neurons.
    Wu X; Tian F; Okagaki P; Marini AM
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):57-67. PubMed ID: 16164961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin B as an intracellular modulator of bone resorption.
    Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
    Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate does not play a major role in controlling bone growth.
    Gray C; Marie H; Arora M; Tanaka K; Boyde A; Jones S; Attwell D
    J Bone Miner Res; 2001 Apr; 16(4):742-9. PubMed ID: 11316002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.